-
1
-
-
0024843541
-
-
1. a) Shinozaki, H.; Ishida, M.; Shimamoto, K.; Ohfune, Y. Br. J. Pharmacol. 1989, 98, 1213.
-
(1989)
Br. J. Pharmacol.
, vol.98
, pp. 1213
-
-
Shinozaki, H.1
Ishida, M.2
Shimamoto, K.3
Ohfune, Y.4
-
2
-
-
0024495582
-
-
b) Shinozaki, H.; Ishida, M.; Shimamoto, K.; Ohfune, Y. Brain Res. 1989, 480, 355.
-
(1989)
Brain Res.
, vol.480
, pp. 355
-
-
Shinozaki, H.1
Ishida, M.2
Shimamoto, K.3
Ohfune, Y.4
-
3
-
-
0025797354
-
-
c) Shimamoto, K.; Ishida, M.; Shinozaki, H.; Ohfune, Y. J. Org. Chem. 1991, 56, 4167.
-
(1991)
J. Org. Chem.
, vol.56
, pp. 4167
-
-
Shimamoto, K.1
Ishida, M.2
Shinozaki, H.3
Ohfune, Y.4
-
4
-
-
0026503073
-
-
d) Kawai, M.; Horikawa, Y.; Ishihara, T.; Shimamoto, K.; Ohfune, Y. Eur. J. Pharmacol. 1992, 211, 195.
-
(1992)
Eur. J. Pharmacol.
, vol.211
, pp. 195
-
-
Kawai, M.1
Horikawa, Y.2
Ishihara, T.3
Shimamoto, K.4
Ohfune, Y.5
-
6
-
-
0028928489
-
-
b) Knöpfel, T.; Kuhn, R.; Allgeier, H. J. Med. Chem. 1995, 38, 1417.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 1417
-
-
Knöpfel, T.1
Kuhn, R.2
Allgeier, H.3
-
7
-
-
0030029427
-
-
c) Nicolletti, F.; Bruno, V.; Copani, G.; Casabona, G.; Knöpfel, T. Trend Neurosci. 1996, 19, 267.
-
(1996)
Trend Neurosci.
, vol.19
, pp. 267
-
-
Nicolletti, F.1
Bruno, V.2
Copani, G.3
Casabona, G.4
Knöpfel, T.5
-
8
-
-
0025696335
-
-
3. a) Ishida, M.; Akagi, H.; Shimamoto, K.; Ohfune, Y.; Shinozaki, H. Brain Res. 1990, 537, 311.
-
(1990)
Brain Res.
, vol.537
, pp. 311
-
-
Ishida, M.1
Akagi, H.2
Shimamoto, K.3
Ohfune, Y.4
Shinozaki, H.5
-
9
-
-
0025079146
-
-
b) Nakagawa, Y.; Saito, K.; Ishihara, T.; Ishida, M.; Shinozaki, H. Eur. J. Pharmacol. 1990, 184, 205,
-
(1990)
Eur. J. Pharmacol.
, vol.184
, pp. 205
-
-
Nakagawa, Y.1
Saito, K.2
Ishihara, T.3
Ishida, M.4
Shinozaki, H.5
-
11
-
-
0027967167
-
-
d) Kaba, A.; Hayashi, Y.; Higuchi, T.; Nakanishi, S. Science 1994, 265, 262.
-
(1994)
Science
, vol.265
, pp. 262
-
-
Kaba, A.1
Hayashi, Y.2
Higuchi, T.3
Nakanishi, S.4
-
12
-
-
0027209890
-
-
4. a) Ishida, M.; Saitoh, T.; Shimamoto, K.; Ohfune, Y.; Shinozaki, H. Br. J. Pharmacol. 1993, 109, 1169.
-
(1993)
Br. J. Pharmacol.
, vol.109
, pp. 1169
-
-
Ishida, M.1
Saitoh, T.2
Shimamoto, K.3
Ohfune, Y.4
Shinozaki, H.5
-
13
-
-
0027435172
-
-
b) Ishida, M.; Saitoh, T.; Shinozaki, H. Neurosci. Lett. 1993, 160, 156.
-
(1993)
Neurosci. Lett.
, vol.160
, pp. 156
-
-
Ishida, M.1
Saitoh, T.2
Shinozaki, H.3
-
15
-
-
0010494892
-
-
d) Pellicciarri, R.; Marinozzi, M.; Natalini, B.; Constantino, G.; Luneia, R.; Giorgi, G.; Morini, F.; Thomsen, C. J. Med. Chem. 1995, 38, 2259.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2259
-
-
Pellicciarri, R.1
Marinozzi, M.2
Natalini, B.3
Constantino, G.4
Luneia, R.5
Giorgi, G.6
Morini, F.7
Thomsen, C.8
-
19
-
-
0001834675
-
-
Ojima, I.; McCarthy, J. R.; Welch, J. T. Eds.; ACS Symposium series 639: Washington DC
-
c) Kirk, K. L.; Filler, R. In Biomedical Frontiers of Fluorine Chemistry, Ojima, I.; McCarthy, J. R.; Welch, J. T. Eds.; ACS Symposium series 639: Washington DC, 1996; pp1-24.
-
(1996)
Biomedical Frontiers of Fluorine Chemistry
, pp. 1-24
-
-
Kirk, K.L.1
Filler, R.2
-
21
-
-
33748632563
-
-
7. a) Cha, I. K.; Christ, W. J.; Kishi, Y. Tetrahedron 1984, 40, 2247.
-
(1984)
Tetrahedron
, vol.40
, pp. 2247
-
-
Cha, I.K.1
Christ, W.J.2
Kishi, Y.3
-
22
-
-
0028347971
-
-
b) Morikawa, T.; Sasaki, H.; Hanai, R.; Shibuya, A.; Taguchi, T. J. Org. Chem. 1994, 59, 97.
-
(1994)
J. Org. Chem.
, vol.59
, pp. 97
-
-
Morikawa, T.1
Sasaki, H.2
Hanai, R.3
Shibuya, A.4
Taguchi, T.5
-
23
-
-
0027965577
-
-
8. Taguchi, T.; Shibuya, A.; Sasaki, H.; Endo, J.; Morikawa, T.; Shiro, M. Tetrahedron: Asymmetry 1994, 5, 1423.
-
(1994)
Tetrahedron: Asymmetry
, vol.5
, pp. 1423
-
-
Taguchi, T.1
Shibuya, A.2
Sasaki, H.3
Endo, J.4
Morikawa, T.5
Shiro, M.6
-
24
-
-
0026760618
-
-
9. Irako, N.; Hamada, Y.; Shioiri, T. Tetrahedron 1992, 48, 7251.
-
(1992)
Tetrahedron
, vol.48
, pp. 7251
-
-
Irako, N.1
Hamada, Y.2
Shioiri, T.3
-
25
-
-
2542433188
-
-
10. a) Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B.; J. Org. Chem. 1981, 46, 3936.
-
(1981)
J. Org. Chem.
, vol.46
, pp. 3936
-
-
Carlsen, P.H.J.1
Katsuki, T.2
Martin, V.S.3
Sharpless, K.B.4
-
27
-
-
0010492677
-
-
note
-
2CCG-IV, +70.8.
-
-
-
-
28
-
-
0010458227
-
-
note
-
2CCGs, X-ray crystallographic analysis of one of the lactam derivatives, (2R,1'S, 2'R)-14, was carried out.
-
-
-
-
30
-
-
0019723082
-
-
14. Davies, J.; Francis, A. A.; Jones, A. W.; Watkins, J. C. Neurosci. Lett. 1981, 21, 77.
-
(1981)
Neurosci. Lett.
, vol.21
, pp. 77
-
-
Davies, J.1
Francis, A.A.2
Jones, A.W.3
Watkins, J.C.4
-
31
-
-
0023767546
-
-
15. Honore, T.; Davies, S. N.; Drejer, J.; Fletcher, E. J.; Jacobsen, P.; Lodge, D.; Nielsen, F. Science 1988, 241, 701.
-
(1988)
Science
, vol.241
, pp. 701
-
-
Honore, T.1
Davies, S.N.2
Drejer, J.3
Fletcher, E.J.4
Jacobsen, P.5
Lodge, D.6
Nielsen, F.7
-
32
-
-
0028177522
-
-
16. a) Kemp, M.; Roberts, P.; Pook, P.; Jane, D.; Jones, A.; Jones, P.; Sunter, D.; Udvarhelyi, P.; Watkins, J. C. Eur. J. Pharmacol. Mol. Phamacol. Sect. 1994, 266, 187.
-
(1994)
Eur. J. Pharmacol. Mol. Phamacol. Sect.
, vol.266
, pp. 187
-
-
Kemp, M.1
Roberts, P.2
Pook, P.3
Jane, D.4
Jones, A.5
Jones, P.6
Sunter, D.7
Udvarhelyi, P.8
Watkins, J.C.9
-
34
-
-
0027441565
-
-
17. a) Robinson, M. B.; Sinor, J. D.; Dowd, L. A.;Kerwin, J. F. Jr. J. Neurochem. 1993, 60, 167.
-
(1993)
J. Neurochem.
, vol.60
, pp. 167
-
-
Robinson, M.B.1
Sinor, J.D.2
Dowd, L.A.3
Kerwin J.F., Jr.4
-
35
-
-
0027216795
-
-
b) Nakamura, Y.; Kataoka, K.; Ishida, M.; Shinozaki, H. Neuropharmacology 1993, 32, 833.
-
(1993)
Neuropharmacology
, vol.32
, pp. 833
-
-
Nakamura, Y.1
Kataoka, K.2
Ishida, M.3
Shinozaki, H.4
-
36
-
-
0028245013
-
-
18. a) Jane, D. E.; Jones, P. L. St.J.; Pook, P. C-K.; Tse, H-W.; Watkins, J. C. Br. J. Pharmacol. 1994, 112, 809.
-
(1994)
Br. J. Pharmacol.
, vol.112
, pp. 809
-
-
Jane, D.E.1
Jones, P.L.St.J.2
Pook, P.C.-K.3
Tse, H.-W.4
Watkins, J.C.5
-
37
-
-
0029118768
-
-
b) Knöpfel, T. S.; Leonardt, L. T.; Flor, P. J.; Kuhn, R.; Gasparini, F. Neuropharmacology 1995, 34, 1099.
-
(1995)
Neuropharmacology
, vol.34
, pp. 1099
-
-
Knöpfel, T.S.1
Leonardt, L.T.2
Flor, P.J.3
Kuhn, R.4
Gasparini, F.5
-
38
-
-
0029917495
-
-
c) Bushell, T. J.; Jane, D. E.; Tse, H-W.; Watkins, J. C.; Garthwaite, J.; Collingridge, G. L. Br. J. Pharmacol. 1996, 117, 1457.
-
(1996)
Br. J. Pharmacol.
, vol.117
, pp. 1457
-
-
Bushell, T.J.1
Jane, D.E.2
Tse, H.-W.3
Watkins, J.C.4
Garthwaite, J.5
Collingridge, G.L.6
-
39
-
-
0029131705
-
-
19. a) Jane, D. E.; Pittaway, K.; Sunter, D. C.; Thomas, N. K.; Watkins, J. C. Neuropharmacology 1995, 34, 851.
-
(1995)
Neuropharmacology
, vol.34
, pp. 851
-
-
Jane, D.E.1
Pittaway, K.2
Sunter, D.C.3
Thomas, N.K.4
Watkins, J.C.5
-
41
-
-
0010451398
-
-
note
-
2CCG-I showed the "priming effect" related to the inhibitory action on the monosynaptic spinal reflex. See ref. 13.
-
-
-
-
42
-
-
0010523555
-
-
note
-
2CCG-I; 2.2, 4.3, 9.7 for L-glutamic acid and 1.9, 4.2, 9.7 for CCG-I, respectively.
-
-
-
|